Cardiogenic shock complicating myocardial infarction and outcome following percutaneous coronary intervention.
Cardiogenic shock is the commonest cause of death in acute myocardial infarction (AMI). Although the syndrome of cardiogenic shock complicating AMI is common to all, the spectrum of underlying pathology is broad. While thrombolysis can be attempted with inotropic support or augmentation of blood pressure with an intra-aortic balloon pump, the greatest mortality benefit is seen after urgent coronary angiography and early revascularization. The long-term SHOCK Trial six-year follow-up results confirm durability of early revascularization over medical stabilization in shock patients. Indeed, cardiogenic shock is a catheter laboratory emergency. Percutaneous left ventricular assist devices may provide an advance in the management of patients with left ventricular dysfunction and cardiogenic shock.
Lee
Kaeng W
KW
The Heart and Lung Centre, Wolverhampton Hospital NHS Trust, Wolverhampton, UK
Norell
Michael S
MS
D054058:Acute Coronary Syndrome / Q000150:complications; D015906:Angioplasty, Balloon, Coronary; D002037:Bundle-Branch Block / Q000150:complications; D017023:Coronary Angiography; D001026:Coronary Artery Bypass; D006353:Heart-Assist Devices; D006801:Humans; D008944:Mitral Valve Insufficiency / Q000150:complications; D009203:Myocardial Infarction / Q000150:complications* / Q000401:mortality / Q000628:therapy*; D012770:Shock, Cardiogenic / Q000175:diagnosis / Q000209:etiology* / Q000401:mortality; D016019:Survival Analysis; D016896:Treatment Outcome